Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure
In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69
Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse
DCPC Developing Hispanic Cancer Control Intervention Program Concept
Boston Meeting To Look At “IRBs At Crsswoad”
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally
- UT Austin announces first tech-native academic medical center in the U.S.
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book









